AbstractWe looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels of sera from individuals living in metropolitan France, obtained either before, during or after the epidemic, using standard haemagglutination inhibition and microneutralization tests. The difference between seroprevalence values measured in post- and pre-epidemic panels was used as an estimate of seroconversion rate in different age groups (23.4% (0–24 years, age-group 0); 16.5% (25–34); 7.9% (35–44); 7.2% (45–54); 1.6% (55–64); and 3.1% (<65)), confirming that the distribution of cases in different age groups was similar to that of the seasonal H1N1 virus. During the pre-pandemic period low-titre cross-reactive antibodies were present in a l...
International audienceThe CoPanFlu-France cohort of households was set up in 2009 to study the risk ...
Abstract We measured haemagglutination inhibiting (HI) serum antibody titers to vaccine matched A/H1...
International audienceIntroduction : Haemagglutination-inhibition (HI) antibody titer is a correlate...
AbstractWe looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels o...
We looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels of sera f...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
AbstractThe new influenza strain detected in humans in April 2009 has caused the first influenza pan...
Background: In order to detect levels of pre-existing cross-reactive antibodies in different age gro...
Background: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
AbstractWe measured haemagglutination inhibiting (HI) serum antibody titers to vaccine matched A/H1N...
International audienceThe CoPanFlu-France cohort of households was set up in 2009 to study the risk ...
Abstract We measured haemagglutination inhibiting (HI) serum antibody titers to vaccine matched A/H1...
International audienceIntroduction : Haemagglutination-inhibition (HI) antibody titer is a correlate...
AbstractWe looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels o...
We looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels of sera f...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
AbstractThe new influenza strain detected in humans in April 2009 has caused the first influenza pan...
Background: In order to detect levels of pre-existing cross-reactive antibodies in different age gro...
Background: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
AbstractWe measured haemagglutination inhibiting (HI) serum antibody titers to vaccine matched A/H1N...
International audienceThe CoPanFlu-France cohort of households was set up in 2009 to study the risk ...
Abstract We measured haemagglutination inhibiting (HI) serum antibody titers to vaccine matched A/H1...
International audienceIntroduction : Haemagglutination-inhibition (HI) antibody titer is a correlate...